▶ 調査レポート

世界の手術用止血鉗子・内部組織シーラント・接着バリア市場規模・現状・予測(2021年-2027年)

• 英文タイトル:Global Surgical Hemostats, Internal Tissue Sealants, and Adhesion Barriers Market Size, Status and Forecast 2021-2027

QYResearchが調査・発行した産業分析レポートです。世界の手術用止血鉗子・内部組織シーラント・接着バリア市場規模・現状・予測(2021年-2027年) / Global Surgical Hemostats, Internal Tissue Sealants, and Adhesion Barriers Market Size, Status and Forecast 2021-2027 / QYR2104Z5509資料のイメージです。• レポートコード:QYR2104Z5509
• 出版社/出版日:QYResearch / 2021年4月
※2025年版があります。お問い合わせください。

• レポート形態:英文、PDF、98ページ
• 納品方法:Eメール(納期:3日)
• 産業分類:医療機器
• 販売価格(消費税別)
  Single User¥546,000 (USD3,900)▷ お問い合わせ
  Multi User/Five User¥819,000 (USD5,850)▷ お問い合わせ
  Enterprise License(同一法人内共有可)¥1,092,000 (USD7,800)▷ お問い合わせ
• ご注文方法:お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法:銀行振込(納品後、ご請求書送付)
レポート概要
QYResearch社発行の本調査資料では、手術用止血鉗子・内部組織シーラント・接着バリアのグローバル市場(2016年~2027年)について調べ、市場動向、主要企業の市場シェア、種類別市場規模(止血鉗子、内部組織シーラント、癒着バリア)、用途別市場規模(病院、クリニック&トラウマセンター、外来手術センター)、主要地域別市場規模(北米、アメリカ、ヨーロッパ、アジア、日本、中国、韓国、インド、東南アジア、中南米、中東、アフリカ等)、関連企業情報などを掲載しています。
・市場概要
・手術用止血鉗子・内部組織シーラント・接着バリアの市場動向
・企業の競争状況、市場シェア
・手術用止血鉗子・内部組織シーラント・接着バリアの種類別市場規模(止血鉗子、内部組織シーラント、癒着バリア)
・手術用止血鉗子・内部組織シーラント・接着バリアの用途別市場規模(病院、クリニック&トラウマセンター、外来手術センター)
・手術用止血鉗子・内部組織シーラント・接着バリアの北米市場規模2016-2027(アメリカ、カナダ)
・手術用止血鉗子・内部組織シーラント・接着バリアのヨーロッパ市場規模2016-2027(ドイツ、フランス、イギリス等)
・手術用止血鉗子・内部組織シーラント・接着バリアのアジア市場規模2016-2027(日本、中国、韓国、インド、東南アジア等)
・手術用止血鉗子・内部組織シーラント・接着バリアの中南米市場規模2016-2027(メキシコ、ブラジル)
・手術用止血鉗子・内部組織シーラント・接着バリアの中東・アフリカ市場規模2016-2027(トルコ、サウジアラビア等)
・主要企業情報(Baxter、Ethicon、B. Braun Melsungen、Sanofi、C. R. Bard、Integra Lifesciences、Cryolife、Tissuemed、Cohera Medical、Pfizer)
・結論

Increasing geriatric population across the globe coupled with increasing demand for cardiovascular, orthopaedic, digestive, and other surgical procedures is expected to fuel consumption of surgical hemostats, internal tissue sealants and adhesion barriers market.
Primary factors fuelling demand for surgical hemostats, internal tissue sealants and adhesion barriers are rapidly ageing population with rising cardiovascular, digestive, orthopaedic and other surgical procedures, strong healthcare consciousness and availability of new surgical adhesives for various surgical application.

Market Analysis and Insights: Global Surgical Hemostats, Internal Tissue Sealants, and Adhesion Barriers Market
The global Surgical Hemostats, Internal Tissue Sealants, and Adhesion Barriers market size is projected to reach US$ 6641.4 million by 2026, from US$ 4076.5 million in 2019, at a CAGR of 7.1% during 2021-2026.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Surgical Hemostats, Internal Tissue Sealants, and Adhesion Barriers market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Surgical Hemostats, Internal Tissue Sealants, and Adhesion Barriers market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Surgical Hemostats, Internal Tissue Sealants, and Adhesion Barriers market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Surgical Hemostats, Internal Tissue Sealants, and Adhesion Barriers market.

Global Surgical Hemostats, Internal Tissue Sealants, and Adhesion Barriers Scope and Market Size
Surgical Hemostats, Internal Tissue Sealants, and Adhesion Barriers market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Surgical Hemostats, Internal Tissue Sealants, and Adhesion Barriers market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.

Segment by Type
Hemostats
Internal Tissue Sealants
Adhesion Barriers

Segment by Application
Hospitals
Clinics & Trauma Centers
Ambulatory Surgical Centers

By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA

By Company
Baxter
Ethicon
B. Braun Melsungen
Sanofi
C. R. Bard
Integra Lifesciences
Cryolife
Tissuemed
Cohera Medical

レポート目次

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Surgical Hemostats, Internal Tissue Sealants, and Adhesion Barriers Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 Hemostats
1.2.3 Internal Tissue Sealants
1.2.4 Adhesion Barriers
1.3 Market by Application
1.3.1 Global Surgical Hemostats, Internal Tissue Sealants, and Adhesion Barriers Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Hospitals
1.3.3 Clinics & Trauma Centers
1.3.4 Ambulatory Surgical Centers
1.4 Study Objectives
1.5 Years Considered

2 Global Growth Trends
2.1 Global Surgical Hemostats, Internal Tissue Sealants, and Adhesion Barriers Market Perspective (2016-2027)
2.2 Surgical Hemostats, Internal Tissue Sealants, and Adhesion Barriers Growth Trends by Regions
2.2.1 Surgical Hemostats, Internal Tissue Sealants, and Adhesion Barriers Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Surgical Hemostats, Internal Tissue Sealants, and Adhesion Barriers Historic Market Share by Regions (2016-2021)
2.2.3 Surgical Hemostats, Internal Tissue Sealants, and Adhesion Barriers Forecasted Market Size by Regions (2022-2027)
2.3 Surgical Hemostats, Internal Tissue Sealants, and Adhesion Barriers Industry Dynamic
2.3.1 Surgical Hemostats, Internal Tissue Sealants, and Adhesion Barriers Market Trends
2.3.2 Surgical Hemostats, Internal Tissue Sealants, and Adhesion Barriers Market Drivers
2.3.3 Surgical Hemostats, Internal Tissue Sealants, and Adhesion Barriers Market Challenges
2.3.4 Surgical Hemostats, Internal Tissue Sealants, and Adhesion Barriers Market Restraints

3 Competition Landscape by Key Players
3.1 Global Top Surgical Hemostats, Internal Tissue Sealants, and Adhesion Barriers Players by Revenue
3.1.1 Global Top Surgical Hemostats, Internal Tissue Sealants, and Adhesion Barriers Players by Revenue (2016-2021)
3.1.2 Global Surgical Hemostats, Internal Tissue Sealants, and Adhesion Barriers Revenue Market Share by Players (2016-2021)
3.2 Global Surgical Hemostats, Internal Tissue Sealants, and Adhesion Barriers Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Surgical Hemostats, Internal Tissue Sealants, and Adhesion Barriers Revenue
3.4 Global Surgical Hemostats, Internal Tissue Sealants, and Adhesion Barriers Market Concentration Ratio
3.4.1 Global Surgical Hemostats, Internal Tissue Sealants, and Adhesion Barriers Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Surgical Hemostats, Internal Tissue Sealants, and Adhesion Barriers Revenue in 2020
3.5 Surgical Hemostats, Internal Tissue Sealants, and Adhesion Barriers Key Players Head office and Area Served
3.6 Key Players Surgical Hemostats, Internal Tissue Sealants, and Adhesion Barriers Product Solution and Service
3.7 Date of Enter into Surgical Hemostats, Internal Tissue Sealants, and Adhesion Barriers Market
3.8 Mergers & Acquisitions, Expansion Plans

4 Surgical Hemostats, Internal Tissue Sealants, and Adhesion Barriers Breakdown Data by Type
4.1 Global Surgical Hemostats, Internal Tissue Sealants, and Adhesion Barriers Historic Market Size by Type (2016-2021)
4.2 Global Surgical Hemostats, Internal Tissue Sealants, and Adhesion Barriers Forecasted Market Size by Type (2022-2027)

5 Surgical Hemostats, Internal Tissue Sealants, and Adhesion Barriers Breakdown Data by Application
5.1 Global Surgical Hemostats, Internal Tissue Sealants, and Adhesion Barriers Historic Market Size by Application (2016-2021)
5.2 Global Surgical Hemostats, Internal Tissue Sealants, and Adhesion Barriers Forecasted Market Size by Application (2022-2027)

6 North America
6.1 North America Surgical Hemostats, Internal Tissue Sealants, and Adhesion Barriers Market Size (2016-2027)
6.2 North America Surgical Hemostats, Internal Tissue Sealants, and Adhesion Barriers Market Size by Type
6.2.1 North America Surgical Hemostats, Internal Tissue Sealants, and Adhesion Barriers Market Size by Type (2016-2021)
6.2.2 North America Surgical Hemostats, Internal Tissue Sealants, and Adhesion Barriers Market Size by Type (2022-2027)
6.2.3 North America Surgical Hemostats, Internal Tissue Sealants, and Adhesion Barriers Market Size by Type (2016-2027)
6.3 North America Surgical Hemostats, Internal Tissue Sealants, and Adhesion Barriers Market Size by Application
6.3.1 North America Surgical Hemostats, Internal Tissue Sealants, and Adhesion Barriers Market Size by Application (2016-2021)
6.3.2 North America Surgical Hemostats, Internal Tissue Sealants, and Adhesion Barriers Market Size by Application (2022-2027)
6.3.3 North America Surgical Hemostats, Internal Tissue Sealants, and Adhesion Barriers Market Size by Application (2016-2027)
6.4 North America Surgical Hemostats, Internal Tissue Sealants, and Adhesion Barriers Market Size by Country
6.4.1 North America Surgical Hemostats, Internal Tissue Sealants, and Adhesion Barriers Market Size by Country (2016-2021)
6.4.2 North America Surgical Hemostats, Internal Tissue Sealants, and Adhesion Barriers Market Size by Country (2022-2027)
6.4.3 United States
6.4.3 Canada

7 Europe
7.1 Europe Surgical Hemostats, Internal Tissue Sealants, and Adhesion Barriers Market Size (2016-2027)
7.2 Europe Surgical Hemostats, Internal Tissue Sealants, and Adhesion Barriers Market Size by Type
7.2.1 Europe Surgical Hemostats, Internal Tissue Sealants, and Adhesion Barriers Market Size by Type (2016-2021)
7.2.2 Europe Surgical Hemostats, Internal Tissue Sealants, and Adhesion Barriers Market Size by Type (2022-2027)
7.2.3 Europe Surgical Hemostats, Internal Tissue Sealants, and Adhesion Barriers Market Size by Type (2016-2027)
7.3 Europe Surgical Hemostats, Internal Tissue Sealants, and Adhesion Barriers Market Size by Application
7.3.1 Europe Surgical Hemostats, Internal Tissue Sealants, and Adhesion Barriers Market Size by Application (2016-2021)
7.3.2 Europe Surgical Hemostats, Internal Tissue Sealants, and Adhesion Barriers Market Size by Application (2022-2027)
7.3.3 Europe Surgical Hemostats, Internal Tissue Sealants, and Adhesion Barriers Market Size by Application (2016-2027)
7.4 Europe Surgical Hemostats, Internal Tissue Sealants, and Adhesion Barriers Market Size by Country
7.4.1 Europe Surgical Hemostats, Internal Tissue Sealants, and Adhesion Barriers Market Size by Country (2016-2021)
7.4.2 Europe Surgical Hemostats, Internal Tissue Sealants, and Adhesion Barriers Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic

8 Asia-Pacific
8.1 Asia-Pacific Surgical Hemostats, Internal Tissue Sealants, and Adhesion Barriers Market Size (2016-2027)
8.2 Asia-Pacific Surgical Hemostats, Internal Tissue Sealants, and Adhesion Barriers Market Size by Type
8.2.1 Asia-Pacific Surgical Hemostats, Internal Tissue Sealants, and Adhesion Barriers Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Surgical Hemostats, Internal Tissue Sealants, and Adhesion Barriers Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Surgical Hemostats, Internal Tissue Sealants, and Adhesion Barriers Market Size by Type (2016-2027)
8.3 Asia-Pacific Surgical Hemostats, Internal Tissue Sealants, and Adhesion Barriers Market Size by Application
8.3.1 Asia-Pacific Surgical Hemostats, Internal Tissue Sealants, and Adhesion Barriers Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Surgical Hemostats, Internal Tissue Sealants, and Adhesion Barriers Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Surgical Hemostats, Internal Tissue Sealants, and Adhesion Barriers Market Size by Application (2016-2027)
8.4 Asia-Pacific Surgical Hemostats, Internal Tissue Sealants, and Adhesion Barriers Market Size by Region
8.4.1 Asia-Pacific Surgical Hemostats, Internal Tissue Sealants, and Adhesion Barriers Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Surgical Hemostats, Internal Tissue Sealants, and Adhesion Barriers Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia

9 Latin America
9.1 Latin America Surgical Hemostats, Internal Tissue Sealants, and Adhesion Barriers Market Size (2016-2027)
9.2 Latin America Surgical Hemostats, Internal Tissue Sealants, and Adhesion Barriers Market Size by Type
9.2.1 Latin America Surgical Hemostats, Internal Tissue Sealants, and Adhesion Barriers Market Size by Type (2016-2021)
9.2.2 Latin America Surgical Hemostats, Internal Tissue Sealants, and Adhesion Barriers Market Size by Type (2022-2027)
9.2.3 Latin America Surgical Hemostats, Internal Tissue Sealants, and Adhesion Barriers Market Size by Type (2016-2027)
9.3 Latin America Surgical Hemostats, Internal Tissue Sealants, and Adhesion Barriers Market Size by Application
9.3.1 Latin America Surgical Hemostats, Internal Tissue Sealants, and Adhesion Barriers Market Size by Application (2016-2021)
9.3.2 Latin America Surgical Hemostats, Internal Tissue Sealants, and Adhesion Barriers Market Size by Application (2022-2027)
9.3.3 Latin America Surgical Hemostats, Internal Tissue Sealants, and Adhesion Barriers Market Size by Application (2016-2027)
9.4 Latin America Surgical Hemostats, Internal Tissue Sealants, and Adhesion Barriers Market Size by Country
9.4.1 Latin America Surgical Hemostats, Internal Tissue Sealants, and Adhesion Barriers Market Size by Country (2016-2021)
9.4.2 Latin America Surgical Hemostats, Internal Tissue Sealants, and Adhesion Barriers Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil

10 Middle East & Africa
10.1 Middle East & Africa Surgical Hemostats, Internal Tissue Sealants, and Adhesion Barriers Market Size (2016-2027)
10.2 Middle East & Africa Surgical Hemostats, Internal Tissue Sealants, and Adhesion Barriers Market Size by Type
10.2.1 Middle East & Africa Surgical Hemostats, Internal Tissue Sealants, and Adhesion Barriers Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Surgical Hemostats, Internal Tissue Sealants, and Adhesion Barriers Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Surgical Hemostats, Internal Tissue Sealants, and Adhesion Barriers Market Size by Type (2016-2027)
10.3 Middle East & Africa Surgical Hemostats, Internal Tissue Sealants, and Adhesion Barriers Market Size by Application
10.3.1 Middle East & Africa Surgical Hemostats, Internal Tissue Sealants, and Adhesion Barriers Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Surgical Hemostats, Internal Tissue Sealants, and Adhesion Barriers Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Surgical Hemostats, Internal Tissue Sealants, and Adhesion Barriers Market Size by Application (2016-2027)
10.4 Middle East & Africa Surgical Hemostats, Internal Tissue Sealants, and Adhesion Barriers Market Size by Country
10.4.1 Middle East & Africa Surgical Hemostats, Internal Tissue Sealants, and Adhesion Barriers Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Surgical Hemostats, Internal Tissue Sealants, and Adhesion Barriers Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE

11 Key Players Profiles
11.1 Baxter
11.1.1 Baxter Company Details
11.1.2 Baxter Business Overview
11.1.3 Baxter Surgical Hemostats, Internal Tissue Sealants, and Adhesion Barriers Introduction
11.1.4 Baxter Revenue in Surgical Hemostats, Internal Tissue Sealants, and Adhesion Barriers Business (2016-2021)
11.1.5 Baxter Recent Development
11.2 Ethicon
11.2.1 Ethicon Company Details
11.2.2 Ethicon Business Overview
11.2.3 Ethicon Surgical Hemostats, Internal Tissue Sealants, and Adhesion Barriers Introduction
11.2.4 Ethicon Revenue in Surgical Hemostats, Internal Tissue Sealants, and Adhesion Barriers Business (2016-2021)
11.2.5 Ethicon Recent Development
11.3 B. Braun Melsungen
11.3.1 B. Braun Melsungen Company Details
11.3.2 B. Braun Melsungen Business Overview
11.3.3 B. Braun Melsungen Surgical Hemostats, Internal Tissue Sealants, and Adhesion Barriers Introduction
11.3.4 B. Braun Melsungen Revenue in Surgical Hemostats, Internal Tissue Sealants, and Adhesion Barriers Business (2016-2021)
11.3.5 B. Braun Melsungen Recent Development
11.4 Sanofi
11.4.1 Sanofi Company Details
11.4.2 Sanofi Business Overview
11.4.3 Sanofi Surgical Hemostats, Internal Tissue Sealants, and Adhesion Barriers Introduction
11.4.4 Sanofi Revenue in Surgical Hemostats, Internal Tissue Sealants, and Adhesion Barriers Business (2016-2021)
11.4.5 Sanofi Recent Development
11.5 C. R. Bard
11.5.1 C. R. Bard Company Details
11.5.2 C. R. Bard Business Overview
11.5.3 C. R. Bard Surgical Hemostats, Internal Tissue Sealants, and Adhesion Barriers Introduction
11.5.4 C. R. Bard Revenue in Surgical Hemostats, Internal Tissue Sealants, and Adhesion Barriers Business (2016-2021)
11.5.5 C. R. Bard Recent Development
11.6 Integra Lifesciences
11.6.1 Integra Lifesciences Company Details
11.6.2 Integra Lifesciences Business Overview
11.6.3 Integra Lifesciences Surgical Hemostats, Internal Tissue Sealants, and Adhesion Barriers Introduction
11.6.4 Integra Lifesciences Revenue in Surgical Hemostats, Internal Tissue Sealants, and Adhesion Barriers Business (2016-2021)
11.6.5 Integra Lifesciences Recent Development
11.7 Cryolife
11.7.1 Cryolife Company Details
11.7.2 Cryolife Business Overview
11.7.3 Cryolife Surgical Hemostats, Internal Tissue Sealants, and Adhesion Barriers Introduction
11.7.4 Cryolife Revenue in Surgical Hemostats, Internal Tissue Sealants, and Adhesion Barriers Business (2016-2021)
11.7.5 Cryolife Recent Development
11.8 Tissuemed
11.8.1 Tissuemed Company Details
11.8.2 Tissuemed Business Overview
11.8.3 Tissuemed Surgical Hemostats, Internal Tissue Sealants, and Adhesion Barriers Introduction
11.8.4 Tissuemed Revenue in Surgical Hemostats, Internal Tissue Sealants, and Adhesion Barriers Business (2016-2021)
11.8.5 Tissuemed Recent Development
11.9 Cohera Medical
11.9.1 Cohera Medical Company Details
11.9.2 Cohera Medical Business Overview
11.9.3 Cohera Medical Surgical Hemostats, Internal Tissue Sealants, and Adhesion Barriers Introduction
11.9.4 Cohera Medical Revenue in Surgical Hemostats, Internal Tissue Sealants, and Adhesion Barriers Business (2016-2021)
11.9.5 Cohera Medical Recent Development
11.10 Pfizer
11.10.1 Pfizer Company Details
11.10.2 Pfizer Business Overview
11.10.3 Pfizer Surgical Hemostats, Internal Tissue Sealants, and Adhesion Barriers Introduction
11.10.4 Pfizer Revenue in Surgical Hemostats, Internal Tissue Sealants, and Adhesion Barriers Business (2016-2021)
11.10.5 Pfizer Recent Development

12 Analyst’s Viewpoints/Conclusions

13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Tables
Table 1. Global Surgical Hemostats, Internal Tissue Sealants, and Adhesion Barriers Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of Hemostats
Table 3. Key Players of Internal Tissue Sealants
Table 4. Key Players of Adhesion Barriers
Table 5. Global Surgical Hemostats, Internal Tissue Sealants, and Adhesion Barriers Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 6. Global Surgical Hemostats, Internal Tissue Sealants, and Adhesion Barriers Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 7. Global Surgical Hemostats, Internal Tissue Sealants, and Adhesion Barriers Market Size by Regions (2016-2021) & (US$ Million)
Table 8. Global Surgical Hemostats, Internal Tissue Sealants, and Adhesion Barriers Market Share by Regions (2016-2021)
Table 9. Global Surgical Hemostats, Internal Tissue Sealants, and Adhesion Barriers Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 10. Global Surgical Hemostats, Internal Tissue Sealants, and Adhesion Barriers Market Share by Regions (2022-2027)
Table 11. Surgical Hemostats, Internal Tissue Sealants, and Adhesion Barriers Market Trends
Table 12. Surgical Hemostats, Internal Tissue Sealants, and Adhesion Barriers Market Drivers
Table 13. Surgical Hemostats, Internal Tissue Sealants, and Adhesion Barriers Market Challenges
Table 14. Surgical Hemostats, Internal Tissue Sealants, and Adhesion Barriers Market Restraints
Table 15. Global Surgical Hemostats, Internal Tissue Sealants, and Adhesion Barriers Revenue by Players (2016-2021) & (US$ Million)
Table 16. Global Surgical Hemostats, Internal Tissue Sealants, and Adhesion Barriers Market Share by Players (2016-2021)
Table 17. Global Top Surgical Hemostats, Internal Tissue Sealants, and Adhesion Barriers Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Surgical Hemostats, Internal Tissue Sealants, and Adhesion Barriers as of 2020)
Table 18. Ranking of Global Top Surgical Hemostats, Internal Tissue Sealants, and Adhesion Barriers Companies by Revenue (US$ Million) in 2020
Table 19. Global 5 Largest Players Market Share by Surgical Hemostats, Internal Tissue Sealants, and Adhesion Barriers Revenue (CR5 and HHI) & (2016-2021)
Table 20. Key Players Headquarters and Area Served
Table 21. Key Players Surgical Hemostats, Internal Tissue Sealants, and Adhesion Barriers Product Solution and Service
Table 22. Date of Enter into Surgical Hemostats, Internal Tissue Sealants, and Adhesion Barriers Market
Table 23. Mergers & Acquisitions, Expansion Plans
Table 24. Global Surgical Hemostats, Internal Tissue Sealants, and Adhesion Barriers Market Size by Type (2016-2021) (US$ Million)
Table 25. Global Surgical Hemostats, Internal Tissue Sealants, and Adhesion Barriers Revenue Market Share by Type (2016-2021)
Table 26. Global Surgical Hemostats, Internal Tissue Sealants, and Adhesion Barriers Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 27. Global Surgical Hemostats, Internal Tissue Sealants, and Adhesion Barriers Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 28. Global Surgical Hemostats, Internal Tissue Sealants, and Adhesion Barriers Market Size Share by Application (2016-2021) & (US$ Million)
Table 29. Global Surgical Hemostats, Internal Tissue Sealants, and Adhesion Barriers Revenue Market Share by Application (2016-2021)
Table 30. Global Surgical Hemostats, Internal Tissue Sealants, and Adhesion Barriers Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 31. Global Surgical Hemostats, Internal Tissue Sealants, and Adhesion Barriers Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 32. North America Surgical Hemostats, Internal Tissue Sealants, and Adhesion Barriers Market Size by Type (2016-2021) (US$ Million)
Table 33. North America Surgical Hemostats, Internal Tissue Sealants, and Adhesion Barriers Market Size by Type (2022-2027) & (US$ Million)
Table 34. North America Surgical Hemostats, Internal Tissue Sealants, and Adhesion Barriers Market Size by Application (2016-2021) (US$ Million)
Table 35. North America Surgical Hemostats, Internal Tissue Sealants, and Adhesion Barriers Market Size by Application (2022-2027) & (US$ Million)
Table 36. North America Surgical Hemostats, Internal Tissue Sealants, and Adhesion Barriers Market Size by Country (2016-2021) & (US$ Million)
Table 37. North America Surgical Hemostats, Internal Tissue Sealants, and Adhesion Barriers Market Size by Country (2022-2027) & (US$ Million)
Table 38. Europe Surgical Hemostats, Internal Tissue Sealants, and Adhesion Barriers Market Size by Type (2016-2021) (US$ Million)
Table 39. Europe Surgical Hemostats, Internal Tissue Sealants, and Adhesion Barriers Market Size by Type (2022-2027) & (US$ Million)
Table 40. Europe Surgical Hemostats, Internal Tissue Sealants, and Adhesion Barriers Market Size by Application (2016-2021) (US$ Million)
Table 41. Europe Surgical Hemostats, Internal Tissue Sealants, and Adhesion Barriers Market Size by Application (2022-2027) & (US$ Million)
Table 42. Europe Surgical Hemostats, Internal Tissue Sealants, and Adhesion Barriers Market Size by Country (2016-2021) & (US$ Million)
Table 43. Europe Surgical Hemostats, Internal Tissue Sealants, and Adhesion Barriers Market Size by Country (2022-2027) & (US$ Million)
Table 44. Asia-Pacific Surgical Hemostats, Internal Tissue Sealants, and Adhesion Barriers Market Size by Type (2016-2021) (US$ Million)
Table 45. Asia-Pacific Surgical Hemostats, Internal Tissue Sealants, and Adhesion Barriers Market Size by Type (2022-2027) & (US$ Million)
Table 46. Asia-Pacific Surgical Hemostats, Internal Tissue Sealants, and Adhesion Barriers Market Size by Application (2016-2021) (US$ Million)
Table 47. Asia-Pacific Surgical Hemostats, Internal Tissue Sealants, and Adhesion Barriers Market Size by Application (2022-2027) & (US$ Million)
Table 48. Asia-Pacific Surgical Hemostats, Internal Tissue Sealants, and Adhesion Barriers Market Size by Region (2016-2021) & (US$ Million)
Table 49. Asia-Pacific Surgical Hemostats, Internal Tissue Sealants, and Adhesion Barriers Market Size by Region (2022-2027) & (US$ Million)
Table 50. Latin America Surgical Hemostats, Internal Tissue Sealants, and Adhesion Barriers Market Size by Type (2016-2021) (US$ Million)
Table 51. Latin America Surgical Hemostats, Internal Tissue Sealants, and Adhesion Barriers Market Size by Type (2022-2027) & (US$ Million)
Table 52. Latin America Surgical Hemostats, Internal Tissue Sealants, and Adhesion Barriers Market Size by Application (2016-2021) (US$ Million)
Table 53. Latin America Surgical Hemostats, Internal Tissue Sealants, and Adhesion Barriers Market Size by Application (2022-2027) & (US$ Million)
Table 54. Latin America Surgical Hemostats, Internal Tissue Sealants, and Adhesion Barriers Market Size by Country (2016-2021) & (US$ Million)
Table 55. Latin America Surgical Hemostats, Internal Tissue Sealants, and Adhesion Barriers Market Size by Country (2022-2027) & (US$ Million)
Table 56. Middle East & Africa Surgical Hemostats, Internal Tissue Sealants, and Adhesion Barriers Market Size by Type (2016-2021) (US$ Million)
Table 57. Middle East & Africa Surgical Hemostats, Internal Tissue Sealants, and Adhesion Barriers Market Size by Type (2022-2027) & (US$ Million)
Table 58. Middle East & Africa Surgical Hemostats, Internal Tissue Sealants, and Adhesion Barriers Market Size by Application (2016-2021) (US$ Million)
Table 59. Middle East & Africa Surgical Hemostats, Internal Tissue Sealants, and Adhesion Barriers Market Size by Application (2022-2027) & (US$ Million)
Table 60. Middle East & Africa Surgical Hemostats, Internal Tissue Sealants, and Adhesion Barriers Market Size by Country (2016-2021) & (US$ Million)
Table 61. Middle East & Africa Surgical Hemostats, Internal Tissue Sealants, and Adhesion Barriers Market Size by Country (2022-2027) & (US$ Million)
Table 62. Baxter Company Details
Table 63. Baxter Business Overview
Table 64. Baxter Surgical Hemostats, Internal Tissue Sealants, and Adhesion Barriers Product
Table 65. Baxter Revenue in Surgical Hemostats, Internal Tissue Sealants, and Adhesion Barriers Business (2016-2021) & (US$ Million)
Table 66. Baxter Recent Development
Table 67. Ethicon Company Details
Table 68. Ethicon Business Overview
Table 69. Ethicon Surgical Hemostats, Internal Tissue Sealants, and Adhesion Barriers Product
Table 70. Ethicon Revenue in Surgical Hemostats, Internal Tissue Sealants, and Adhesion Barriers Business (2016-2021) & (US$ Million)
Table 71. Ethicon Recent Development
Table 72. B. Braun Melsungen Company Details
Table 73. B. Braun Melsungen Business Overview
Table 74. B. Braun Melsungen Surgical Hemostats, Internal Tissue Sealants, and Adhesion Barriers Product
Table 75. B. Braun Melsungen Revenue in Surgical Hemostats, Internal Tissue Sealants, and Adhesion Barriers Business (2016-2021) & (US$ Million)
Table 76. B. Braun Melsungen Recent Development
Table 77. Sanofi Company Details
Table 78. Sanofi Business Overview
Table 79. Sanofi Surgical Hemostats, Internal Tissue Sealants, and Adhesion Barriers Product
Table 80. Sanofi Revenue in Surgical Hemostats, Internal Tissue Sealants, and Adhesion Barriers Business (2016-2021) & (US$ Million)
Table 81. Sanofi Recent Development
Table 82. C. R. Bard Company Details
Table 83. C. R. Bard Business Overview
Table 84. C. R. Bard Surgical Hemostats, Internal Tissue Sealants, and Adhesion Barriers Product
Table 85. C. R. Bard Revenue in Surgical Hemostats, Internal Tissue Sealants, and Adhesion Barriers Business (2016-2021) & (US$ Million)
Table 86. C. R. Bard Recent Development
Table 87. Integra Lifesciences Company Details
Table 88. Integra Lifesciences Business Overview
Table 89. Integra Lifesciences Surgical Hemostats, Internal Tissue Sealants, and Adhesion Barriers Product
Table 90. Integra Lifesciences Revenue in Surgical Hemostats, Internal Tissue Sealants, and Adhesion Barriers Business (2016-2021) & (US$ Million)
Table 91. Integra Lifesciences Recent Development
Table 92. Cryolife Company Details
Table 93. Cryolife Business Overview
Table 94. Cryolife Surgical Hemostats, Internal Tissue Sealants, and Adhesion Barriers Product
Table 95. Cryolife Revenue in Surgical Hemostats, Internal Tissue Sealants, and Adhesion Barriers Business (2016-2021) & (US$ Million)
Table 96. Cryolife Recent Development
Table 97. Tissuemed Company Details
Table 98. Tissuemed Business Overview
Table 99. Tissuemed Revenue in Surgical Hemostats, Internal Tissue Sealants, and Adhesion Barriers Business (2016-2021) & (US$ Million)
Table 100. Tissuemed Recent Development
Table 101. Cohera Medical Company Details
Table 102. Cohera Medical Business Overview
Table 103. Cohera Medical Surgical Hemostats, Internal Tissue Sealants, and Adhesion Barriers Product
Table 104. Cohera Medical Revenue in Surgical Hemostats, Internal Tissue Sealants, and Adhesion Barriers Business (2016-2021) & (US$ Million)
Table 105. Cohera Medical Recent Development
Table 106. Pfizer Company Details
Table 107. Pfizer Business Overview
Table 108. Pfizer Surgical Hemostats, Internal Tissue Sealants, and Adhesion Barriers Product
Table 109. Pfizer Revenue in Surgical Hemostats, Internal Tissue Sealants, and Adhesion Barriers Business (2016-2021) & (US$ Million)
Table 110. Pfizer Recent Development
Table 111. Research Programs/Design for This Report
Table 112. Key Data Information from Secondary Sources
Table 113. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Surgical Hemostats, Internal Tissue Sealants, and Adhesion Barriers Market Share by Type: 2020 VS 2027
Figure 2. Hemostats Features
Figure 3. Internal Tissue Sealants Features
Figure 4. Adhesion Barriers Features
Figure 5. Global Surgical Hemostats, Internal Tissue Sealants, and Adhesion Barriers Market Share by Application: 2020 VS 2027
Figure 6. Hospitals Case Studies
Figure 7. Clinics & Trauma Centers Case Studies
Figure 8. Ambulatory Surgical Centers Case Studies
Figure 9. Surgical Hemostats, Internal Tissue Sealants, and Adhesion Barriers Report Years Considered
Figure 10. Global Surgical Hemostats, Internal Tissue Sealants, and Adhesion Barriers Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 11. Global Surgical Hemostats, Internal Tissue Sealants, and Adhesion Barriers Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 12. Global Surgical Hemostats, Internal Tissue Sealants, and Adhesion Barriers Market Share by Regions: 2020 VS 2027
Figure 13. Global Surgical Hemostats, Internal Tissue Sealants, and Adhesion Barriers Market Share by Regions (2022-2027)
Figure 14. Global Surgical Hemostats, Internal Tissue Sealants, and Adhesion Barriers Market Share by Players in 2020
Figure 15. Global Top Surgical Hemostats, Internal Tissue Sealants, and Adhesion Barriers Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Surgical Hemostats, Internal Tissue Sealants, and Adhesion Barriers as of 2020
Figure 16. The Top 10 and 5 Players Market Share by Surgical Hemostats, Internal Tissue Sealants, and Adhesion Barriers Revenue in 2020
Figure 17. Global Surgical Hemostats, Internal Tissue Sealants, and Adhesion Barriers Revenue Market Share by Type (2016-2021)
Figure 18. Global Surgical Hemostats, Internal Tissue Sealants, and Adhesion Barriers Revenue Market Share by Type (2022-2027)
Figure 19. North America Surgical Hemostats, Internal Tissue Sealants, and Adhesion Barriers Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 20. North America Surgical Hemostats, Internal Tissue Sealants, and Adhesion Barriers Market Share by Type (2016-2027)
Figure 21. North America Surgical Hemostats, Internal Tissue Sealants, and Adhesion Barriers Market Share by Application (2016-2027)
Figure 22. North America Surgical Hemostats, Internal Tissue Sealants, and Adhesion Barriers Market Share by Country (2016-2027)
Figure 23. United States Surgical Hemostats, Internal Tissue Sealants, and Adhesion Barriers Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 24. Canada Surgical Hemostats, Internal Tissue Sealants, and Adhesion Barriers Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 25. Europe Surgical Hemostats, Internal Tissue Sealants, and Adhesion Barriers Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 26. Europe Surgical Hemostats, Internal Tissue Sealants, and Adhesion Barriers Market Share by Type (2016-2027)
Figure 27. Europe Surgical Hemostats, Internal Tissue Sealants, and Adhesion Barriers Market Share by Application (2016-2027)
Figure 28. Europe Surgical Hemostats, Internal Tissue Sealants, and Adhesion Barriers Market Share by Country (2016-2027)
Figure 29. Germany Surgical Hemostats, Internal Tissue Sealants, and Adhesion Barriers Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 30. France Surgical Hemostats, Internal Tissue Sealants, and Adhesion Barriers Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 31. U.K. Surgical Hemostats, Internal Tissue Sealants, and Adhesion Barriers Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 32. Italy Surgical Hemostats, Internal Tissue Sealants, and Adhesion Barriers Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 33. Russia Surgical Hemostats, Internal Tissue Sealants, and Adhesion Barriers Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 34. Nordic Surgical Hemostats, Internal Tissue Sealants, and Adhesion Barriers Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 35. Asia-Pacific Surgical Hemostats, Internal Tissue Sealants, and Adhesion Barriers Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 36. Asia-Pacific Surgical Hemostats, Internal Tissue Sealants, and Adhesion Barriers Market Share by Type (2016-2027)
Figure 37. Asia-Pacific Surgical Hemostats, Internal Tissue Sealants, and Adhesion Barriers Market Share by Application (2016-2027)
Figure 38. Asia-Pacific Surgical Hemostats, Internal Tissue Sealants, and Adhesion Barriers Market Share by Region (2016-2027)
Figure 39. China Surgical Hemostats, Internal Tissue Sealants, and Adhesion Barriers Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 40. Japan Surgical Hemostats, Internal Tissue Sealants, and Adhesion Barriers Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 41. South Korea Surgical Hemostats, Internal Tissue Sealants, and Adhesion Barriers Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 42. Southeast Asia Surgical Hemostats, Internal Tissue Sealants, and Adhesion Barriers Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 43. India Surgical Hemostats, Internal Tissue Sealants, and Adhesion Barriers Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 44. Australia Surgical Hemostats, Internal Tissue Sealants, and Adhesion Barriers Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 45. Latin America Surgical Hemostats, Internal Tissue Sealants, and Adhesion Barriers Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 46. Latin America Surgical Hemostats, Internal Tissue Sealants, and Adhesion Barriers Market Share by Type (2016-2027)
Figure 47. Latin America Surgical Hemostats, Internal Tissue Sealants, and Adhesion Barriers Market Share by Application (2016-2027)
Figure 48. Latin America Surgical Hemostats, Internal Tissue Sealants, and Adhesion Barriers Market Share by Country (2016-2027)
Figure 49. Mexico Surgical Hemostats, Internal Tissue Sealants, and Adhesion Barriers Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 50. Brazil Surgical Hemostats, Internal Tissue Sealants, and Adhesion Barriers Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 51. Middle East & Africa Surgical Hemostats, Internal Tissue Sealants, and Adhesion Barriers Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 52. Middle East & Africa Surgical Hemostats, Internal Tissue Sealants, and Adhesion Barriers Market Share by Type (2016-2027)
Figure 53. Middle East & Africa Surgical Hemostats, Internal Tissue Sealants, and Adhesion Barriers Market Share by Application (2016-2027)
Figure 54. Middle East & Africa Surgical Hemostats, Internal Tissue Sealants, and Adhesion Barriers Market Share by Country (2016-2027)
Figure 55. Turkey Surgical Hemostats, Internal Tissue Sealants, and Adhesion Barriers Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 56. Saudi Arabia Surgical Hemostats, Internal Tissue Sealants, and Adhesion Barriers Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 57. UAE Surgical Hemostats, Internal Tissue Sealants, and Adhesion Barriers Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 58. Baxter Revenue Growth Rate in Surgical Hemostats, Internal Tissue Sealants, and Adhesion Barriers Business (2016-2021)
Figure 59. Ethicon Revenue Growth Rate in Surgical Hemostats, Internal Tissue Sealants, and Adhesion Barriers Business (2016-2021)
Figure 60. B. Braun Melsungen Revenue Growth Rate in Surgical Hemostats, Internal Tissue Sealants, and Adhesion Barriers Business (2016-2021)
Figure 61. Sanofi Revenue Growth Rate in Surgical Hemostats, Internal Tissue Sealants, and Adhesion Barriers Business (2016-2021)
Figure 62. C. R. Bard Revenue Growth Rate in Surgical Hemostats, Internal Tissue Sealants, and Adhesion Barriers Business (2016-2021)
Figure 63. Integra Lifesciences Revenue Growth Rate in Surgical Hemostats, Internal Tissue Sealants, and Adhesion Barriers Business (2016-2021)
Figure 64. Cryolife Revenue Growth Rate in Surgical Hemostats, Internal Tissue Sealants, and Adhesion Barriers Business (2016-2021)
Figure 65. Tissuemed Revenue Growth Rate in Surgical Hemostats, Internal Tissue Sealants, and Adhesion Barriers Business (2016-2021)
Figure 66. Cohera Medical Revenue Growth Rate in Surgical Hemostats, Internal Tissue Sealants, and Adhesion Barriers Business (2016-2021)
Figure 67. Pfizer Revenue Growth Rate in Surgical Hemostats, Internal Tissue Sealants, and Adhesion Barriers Business (2016-2021)
Figure 68. Bottom-up and Top-down Approaches for This Report
Figure 69. Data Triangulation
Figure 70. Key Executives Interviewed